Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy

Uygur M., Yaman I., Altug U., Erol D.

BRITISH JOURNAL OF UROLOGY, cilt.78, sa.2, ss.201-204, 1996 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 78 Sayı: 2
  • Basım Tarihi: 1996
  • Doi Numarası: 10.1046/j.1464-410x.1996.01099.x
  • Dergi Adı: BRITISH JOURNAL OF UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.201-204
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objective To evaluate the efficacy of the conservative management of stage T2 and T3a bladder cancer with deep (radical) transurethral resection (TUR) followed by four cycles of chemotherapy with methotrexate, vinblastine, epirubicin and cisplatin (MVEC) and its impact on bladder preservation and tumour recurrences.